Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Myasthenia Gravis Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Myasthenia Gravis Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Myasthenia Gravis Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Myasthenia Gravis Market-Segmentation by Type 5.1 Congenital Hereditary 5.2 Autoimmune Disease 6 Global Myasthenia Gravis Market-Segmentation by Application 6.1 Hospital 6.2 Medical Clinical Research Center 6.3 Others 7 Global Myasthenia Gravis Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Alexion Pharmaceuticals 8.1.1 Alexion Pharmaceuticals Profile 8.1.2 Alexion Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Alexion Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.1.4 Alexion Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.2 Grifols Therapeutics, 8.2.1 Grifols Therapeutics, Profile 8.2.2 Grifols Therapeutics, Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 Grifols Therapeutics, Product/Solution Launches and Enhancements Analysis 8.2.4 Grifols Therapeutics, Business Overview/Recent Development/Acquisitions 8.3 Astellas Pharma 8.3.1 Astellas Pharma Profile 8.3.2 Astellas Pharma Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Astellas Pharma Product/Solution Launches and Enhancements Analysis 8.3.4 Astellas Pharma Business Overview/Recent Development/Acquisitions 8.4 Novartis 8.4.1 Novartis Profile 8.4.2 Novartis Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Novartis Product/Solution Launches and Enhancements Analysis 8.4.4 Novartis Business Overview/Recent Development/Acquisitions 8.5 Argenx 8.5.1 Argenx Profile 8.5.2 Argenx Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 Argenx Product/Solution Launches and Enhancements Analysis 8.5.4 Argenx Business Overview/Recent Development/Acquisitions 8.6 CSL Behring 8.6.1 CSL Behring Profile 8.6.2 CSL Behring Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 CSL Behring Product/Solution Launches and Enhancements Analysis 8.6.4 CSL Behring Business Overview/Recent Development/Acquisitions 8.7 Mitsubishi Tanabe Pharma 8.7.1 Mitsubishi Tanabe Pharma Profile 8.7.2 Mitsubishi Tanabe Pharma Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 Mitsubishi Tanabe Pharma Product/Solution Launches and Enhancements Analysis 8.7.4 Mitsubishi Tanabe Pharma Business Overview/Recent Development/Acquisitions 8.8 Catalyst Pharmaceuticals 8.8.1 Catalyst Pharmaceuticals Profile 8.8.2 Catalyst Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Catalyst Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.8.4 Catalyst Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.9 Ra Pharmaceuticals 8.9.1 Ra Pharmaceuticals Profile 8.9.2 Ra Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 Ra Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.9.4 Ra Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.10 Valent Pharmaceuticals 8.10.1 Valent Pharmaceuticals Profile 8.10.2 Valent Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.10.3 Valent Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.10.4 Valent Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.11 UCB Pharma 8.11.1 UCB Pharma Profile 8.11.2 UCB Pharma Sales, Growth Rate and Global Market Share from 2014-2019E 8.11.3 UCB Pharma Product/Solution Launches and Enhancements Analysis 8.11.4 UCB Pharma Business Overview/Recent Development/Acquisitions 9 Global Myasthenia Gravis Market-Segmentation by Geography 10 North America 10.1 North America Myasthenia Gravis Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Myasthenia Gravis Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Myasthenia Gravis Production Analysis from 2014-2019E 10.4 North America Myasthenia Gravis Consumption Analysis from 2014-2019E 10.5 North America Myasthenia Gravis Import and Export from 2014-2019E 10.6 North America Myasthenia Gravis Value, Production and Market Share by Type (2014-2019E) 10.7 North America Myasthenia Gravis Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Myasthenia Gravis by Country (United States, Canada) 10.8.1 North America Myasthenia Gravis Sales by Country (2014-2019E) 10.8.2 North America Myasthenia Gravis Consumption Value by Country (2014-2019E) 10.9 North America Myasthenia Gravis Market PEST Analysis 11 Europe 11.1 Europe Myasthenia Gravis Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Myasthenia Gravis Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Myasthenia Gravis Production Analysis from 2014-2019E 11.4 Europe Myasthenia Gravis Consumption Analysis from 2014-2019E 11.5 Europe Myasthenia Gravis Import and Export from 2014-2019E 11.6 Europe Myasthenia Gravis Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Myasthenia Gravis Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Myasthenia Gravis by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Myasthenia Gravis Sales by Country (2014-2019E) 11.8.2 Europe Myasthenia Gravis Consumption Value by Country (2014-2019E) 11.9 Europe Myasthenia Gravis Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Myasthenia Gravis Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Myasthenia Gravis Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Myasthenia Gravis Production Analysis from 2014-2019E 12.4 Asia-Pacific Myasthenia Gravis Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Myasthenia Gravis Import and Export from 2014-2019E 12.6 Asia-Pacific Myasthenia Gravis Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Myasthenia Gravis Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Myasthenia Gravis by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Myasthenia Gravis Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Myasthenia Gravis Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Myasthenia Gravis Market PEST Analysis 13 Latin America 13.1 Latin America Myasthenia Gravis Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Myasthenia Gravis Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Myasthenia Gravis Production Analysis from 2014-2019E 13.4 Latin America Myasthenia Gravis Consumption Analysis from 2014-2019E 13.5 Latin America Myasthenia Gravis Import and Export from 2014-2019E 13.6 Latin America Myasthenia Gravis Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Myasthenia Gravis Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Myasthenia Gravis by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Myasthenia Gravis Sales by Country (2014-2019E) 13.8.2 Latin America Myasthenia Gravis Consumption Value by Country (2014-2019E) 13.9 Latin America Myasthenia Gravis Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Myasthenia Gravis Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Myasthenia Gravis Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Myasthenia Gravis Production Analysis from 2014-2019E 14.4 Middle East & Africa Myasthenia Gravis Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Myasthenia Gravis Import and Export from 2014-2019E 14.6 Middle East & Africa Myasthenia Gravis Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Myasthenia Gravis Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Myasthenia Gravis by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Myasthenia Gravis Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Myasthenia Gravis Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Myasthenia Gravis Market PEST Analysis 15 Future Forecast of the Global Myasthenia Gravis Market from 2018-2026 15.1 Future Forecast of the Global Myasthenia Gravis Market from 2019-2026 Segment by Region 15.2 Global Myasthenia Gravis Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Myasthenia Gravis Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source

List of Tables and Figures Global Myasthenia Gravis Market Value ($) and Growth Rate of Myasthenia Gravis from 2014-2026 Global Myasthenia Gravis Production and Growth Rate Segment by Product Type from 2014-2026F Global Myasthenia Gravis Consumption and Growth Rate Segment by Application from 2014-2019E Figure Myasthenia Gravis Picture Table Product Specifications of Myasthenia Gravis Table Driving Factors for this Market Table Industry News of Myasthenia Gravis Market Figure Value Chain Status of Myasthenia Gravis Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Myasthenia Gravis Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Myasthenia Gravis Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure Congenital Hereditary of Myasthenia Gravis Figure Autoimmune Disease of Myasthenia Gravis Table Global Myasthenia Gravis Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Myasthenia Gravis Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Hospital of Myasthenia Gravis Figure Medical Clinical Research Center of Myasthenia Gravis Figure Others of Myasthenia Gravis Table Global Myasthenia Gravis Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Myasthenia Gravis Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Myasthenia Gravis Figure Online Channel of Myasthenia Gravis Table Alexion Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Alexion Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Alexion Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Alexion Pharmaceuticals Myasthenia Gravis Sales, Price, Revenue, Gross Margin (2014-2019E) Table Grifols Therapeutics, Profile (Company Name, Plants Distribution, Sales Region) Figure Grifols Therapeutics, Sales and Growth Rate from 2014-2019E Figure Grifols Therapeutics, Revenue ($) and Global Market Share from 2014-2019E Table Grifols Therapeutics, Myasthenia Gravis Sales, Price, Revenue, Gross Margin (2014-2019E) Table Astellas Pharma Profile (Company Name, Plants Distribution, Sales Region) Figure Astellas Pharma Sales and Growth Rate from 2014-2019E Figure Astellas Pharma Revenue ($) and Global Market Share from 2014-2019E Table Astellas Pharma Myasthenia Gravis Sales, Price, Revenue, Gross Margin (2014-2019E) Table Novartis Profile (Company Name, Plants Distribution, Sales Region) Figure Novartis Sales and Growth Rate from 2014-2019E Figure Novartis Revenue ($) and Global Market Share from 2014-2019E Table Novartis Myasthenia Gravis Sales, Price, Revenue, Gross Margin (2014-2019E) Table Argenx Profile (Company Name, Plants Distribution, Sales Region) Figure Argenx Sales and Growth Rate from 2014-2019E Figure Argenx Revenue ($) and Global Market Share from 2014-2019E Table Argenx Myasthenia Gravis Sales, Price, Revenue, Gross Margin (2014-2019E) Table CSL Behring Profile (Company Name, Plants Distribution, Sales Region) Figure CSL Behring Sales and Growth Rate from 2014-2019E Figure CSL Behring Revenue ($) and Global Market Share from 2014-2019E Table CSL Behring Myasthenia Gravis Sales, Price, Revenue, Gross Margin (2014-2019E) Table Mitsubishi Tanabe Pharma Profile (Company Name, Plants Distribution, Sales Region) Figure Mitsubishi Tanabe Pharma Sales and Growth Rate from 2014-2019E Figure Mitsubishi Tanabe Pharma Revenue ($) and Global Market Share from 2014-2019E Table Mitsubishi Tanabe Pharma Myasthenia Gravis Sales, Price, Revenue, Gross Margin (2014-2019E) Table Catalyst Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Catalyst Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Catalyst Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Catalyst Pharmaceuticals Myasthenia Gravis Sales, Price, Revenue, Gross Margin (2014-2019E) Table Ra Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Ra Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Ra Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Ra Pharmaceuticals Myasthenia Gravis Sales, Price, Revenue, Gross Margin (2014-2019E) Table Valent Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Valent Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Valent Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Valent Pharmaceuticals Myasthenia Gravis Sales, Price, Revenue, Gross Margin (2014-2019E) Table UCB Pharma Profile (Company Name, Plants Distribution, Sales Region) Figure UCB Pharma Sales and Growth Rate from 2014-2019E Figure UCB Pharma Revenue ($) and Global Market Share from 2014-2019E Table UCB Pharma Myasthenia Gravis Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Myasthenia Gravis Production Value ($) by Region from 2014-2019E Table Global Myasthenia Gravis Production Value Share by Region from 2014-2019E Table Global Myasthenia Gravis Production by Region from 2014-2019E Table Global Myasthenia Gravis Consumption Value ($) by Region from 2014-2019E Table Global Myasthenia Gravis Consumption by Region from 2014-2019E Table North America Myasthenia Gravis Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Myasthenia Gravis Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Myasthenia Gravis Import and Export from 2014-2019E Table North America Myasthenia Gravis Value ($) by Type (2014-2019E) Table North America Myasthenia Gravis Production by Type (2014-2019E) Table North America Myasthenia Gravis Consumption by Application (2014-2019E) Table North America Myasthenia Gravis Consumption by Country (2014-2019E) Table North America Myasthenia Gravis Consumption Value ($) by Country (2014-2019E) Figure North America Myasthenia Gravis Market PEST Analysis Table Europe Myasthenia Gravis Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Myasthenia Gravis Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Myasthenia Gravis Import and Export from 2014-2019E Table Europe Myasthenia Gravis Value ($) by Type (2014-2019E) Table Europe Myasthenia Gravis Production by Type (2014-2019E) Table Europe Myasthenia Gravis Consumption by Application (2014-2019E) Table Europe Myasthenia Gravis Consumption by Country (2014-2019E) Table Europe Myasthenia Gravis Consumption Value ($) by Country (2014-2019E) Figure Europe Myasthenia Gravis Market PEST Analysis Table Asia-Pacific Myasthenia Gravis Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Myasthenia Gravis Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Myasthenia Gravis Import and Export from 2014-2019E Table Asia-Pacific Myasthenia Gravis Value ($) by Type (2014-2019E) Table Asia-Pacific Myasthenia Gravis Production by Type (2014-2019E) Table Asia-Pacific Myasthenia Gravis Consumption by Application (2014-2019E) Table Asia-Pacific Myasthenia Gravis Consumption by Country (2014-2019E) Table Asia-Pacific Myasthenia Gravis Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Myasthenia Gravis Market PEST Analysis Table Latin America Myasthenia Gravis Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Myasthenia Gravis Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Myasthenia Gravis Import and Export from 2014-2019E Table Latin America Myasthenia Gravis Value ($) by Type (2014-2019E) Table Latin America Myasthenia Gravis Production by Type (2014-2019E) Table Latin America Myasthenia Gravis Consumption by Application (2014-2019E) Table Latin America Myasthenia Gravis Consumption by Country (2014-2019E) Table Latin America Myasthenia Gravis Consumption Value ($) by Country (2014-2019E) Figure Latin America Myasthenia Gravis Market PEST Analysis Table Middle East & Africa Myasthenia Gravis Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Myasthenia Gravis Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Myasthenia Gravis Import and Export from 2014-2019E Table Middle East & Africa Myasthenia Gravis Value ($) by Type (2014-2019E) Table Middle East & Africa Myasthenia Gravis Production by Type (2014-2019E) Table Middle East & Africa Myasthenia Gravis Consumption by Application (2014-2019E) Table Middle East & Africa Myasthenia Gravis Consumption by Country (2014-2019E) Table Middle East & Africa Myasthenia Gravis Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Myasthenia Gravis Market PEST Analysis Table Global Myasthenia Gravis Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Myasthenia Gravis Production and Growth Rate Forecast by Region (2019-2026) Table Global Myasthenia Gravis Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Myasthenia Gravis Production and Growth Rate Forecast by Type (2019-2026) Table Global Myasthenia Gravis Consumption and Growth Rate Forecast by Application (2019-2026)